Insights Success Fastest Growing ERP Solution Provider Companies Insights Success innovative 3D Printing Solution | Page 37

We provide a new generation of tools to stimulate novel applications at the forefront of nanotechnology, in additive manufacturing, in life sciences Pascal Behr Co-founder & CEO make smart people think completely “Out of the Box” rather than to let them remain trapped in their existing object scale and product size paradigm. To overcome this challenge, the company has developed multiple relationships with universities and innovation department of various companies. This Swiss nanotechnology company comprises of a heterogeneous team where experienced seniority meets ambitious and well educated young specialists. At Cytosurge, each employee is encouraged to participate in the continuous “Culture at Cytosurge” – a program which aims to actively build a culture every member can recognize. The company works in an environment with lots of freedom promoting natural self-responsibility. About the Pillar of Cytosurge Pascal Behr, Co- founder, and CEO of Cytosurge is redefining technology and leading the industry. After completing his engineering degree in Electricals and Nanotechnology at ETH Zurich and Northwestern University, USA, Pascal finished his doctoral studies in the Laboratory of Biosensors and Bioelectronics at ETH Zurich and started focusing his research on the combination of atomic force microscopy with microfluidics; a technology termed FluidFM. Pascal is a man of excellence. Along with gaining an extreme level of academic knowledge, Pascal has also co-invented several patents related to FluidFM technology. He has been featured in numerous national and international blog posts and newspaper articles as a co- founder of Cytosurge. | August 2017 | and in single cell biology Under Pascal’s guidance, Cytosurge has won various prestigious awards like 2017 “Best Development in 3D Printing” Award from ID TechEx in Berlin, Germany and “Pionierpreis” presented by Zürcher Kantonalbank and Technopark Zurich in 2012 which is the most prestigious Startup award in Switzerland. Apart from leading the team of Cytosurge, Pascal is a Board member in a private Swiss industrial enterprise where he is responsible for innovation and digital transformation. Future of 3D Printing through the Eyes of Cytosurge In general, the 3D printing sector is a fast-growing one and it is important that Cytosurge provides value and benefit due its ability to build very complex structures providing clear technical advantages. Cytosurge said that the future of 3D printing using FluidFM is very different since the technology is opening the possibility to build objects at a significantly smaller scale than any other 3D metal printing technique has achieved so far. Cytosurge’s technologies are offering an additional future benefit to the industry which gives businesses to parallelize the printing process utilizing established semiconductor manufacturing techniques. This possibility opens up new doors regarding manufacturing which stand firm as a difficult challenge for other 3D printing technologies. 35